Showing results (631-640 of 1,794) with videos related to
Sort By:
Pageof 180
Mabs|December 18, 2014
In vitro and in vivo modifications of recombinant and human IgG antibodiesHongcheng Liu, Gomathinayagam Ponniah, Hui-Min Zhang, et al.Mabs|December 18, 2014
The level of HER2 expression is a predictor of antibody-HER2 trafficking behavior in cancer cellsSripad Ram, Dongyoung Kim, Raimund J Ober, et al.Mabs|December 18, 2014
Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokineticsRyutaro Asano, Ippei Shimomura, Shota Konno, et al.Mabs|December 18, 2014
Failure to upregulate cell surface PD-1 is associated with dysregulated stimulation of T cells by TGN1412-like CD28 superagonistThilipan Thaventhiran, Naif Alhumeed, Han X A Yeang, et al.Mabs|December 18, 2014
The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4Nathalie Kersual, Véronique Garambois, Thierry Chardès, et al.Mabs|December 18, 2014
Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymeraseKanyarat Thueng-in, Jeeraphong Thanongsaksrikul, Surasak Jittavisutthikul, et al.Mabs|December 18, 2014
Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibodyYosdel Soto, Niurka Mesa, Yumisley Alfonso, et al.Mabs|December 18, 2014
Effect of formulation on the stability and aerosol performance of a nebulized antibodyRenaud Respaud, Denis Marchand, Christelle Parent, et al.Mabs|August 15, 2017
A Quadrupole Dalton-based multi-attribute method for product characterization, process development, and quality control of therapeutic proteinsWeichen Xu, Rod Brian Jimenez, Rachel Mowery, et al.Mabs|August 17, 2017
IgG cooperativity - Is there allostery? Implications for antibody functions and therapeutic antibody developmentDanlin Yang, Rachel Kroe-Barrett, Sanjaya Singh, et al.Pageof 180